NYSE$CHE

Chemed Corp · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Chemed's financial performance in Q1 2021 was reported, featuring revenue growth and increased EPS, alongside segment-specific results for VITAS and Roto-Rooter.

Chemed Corporation reported a 2.2% increase in revenue to $527 million for Q1 2021. GAAP Diluted EPS increased by 18.6% to $4.01, and Adjusted Diluted EPS rose by 20.7% to $4.44. The VITAS segment experienced a revenue decline, while Roto-Rooter saw significant revenue growth.

  • Chemed's revenue increased by 2.2% to $527 million.
  • GAAP Diluted EPS increased by 18.6% to $4.01.
  • Roto-Rooter's revenue increased by 18.9% to $212 million.
  • VITAS Healthcare's net patient revenue decreased by 6.5% to $316 million.

Headline financials

Total Revenue

$527M

Previous: $516M+2.2%
EPS (adj)

$4.44

Previous: $3.68+20.7%
Average Daily Census

18.1K

Previous: 19.2K-6.1%
VITAS Admissions

18.1K

Previous: 18.6K-2.5%
Capital Expenditures

-$17.7M

Previous: -$19.9M+11.1%
Free Cash Flow

$47.7M

Previous: $36M+32.5%
Net Income

$65.4M

Previous: $55.9M+17.0%
Operating Income

$80.4M

Previous: $79.4M+1.4%
Gross Profit

$187M

Previous: $164M+13.9%
Cash & Equivalents

$210M

Previous: $29M+625.9%
Total Assets

$1.46B

Previous: $1.28B+14.1%

Revenue & EPS history

Chemed · Revenue · Quarterly

$527M

Q1 2021+2.2%vs Q1 2020
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Chemed · $528M total across 2 segments · Q1 2021

  • VITAS Healthcare
    $316M-6.5%
  • Roto-Rooter
    $212M+19.1%

Forward guidance

Management anticipates providing updated 2021 earnings guidance in July 2021 as part of the June 30, 2021, earnings press release.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.7%

Avg return

Earnings day

+0.9%

Avg return

5 days after

+2.1%

Avg return

30 days after

53%

36 / 68 earnings

Positive

+13.0%

Q3 2015

Best reaction

-14.8%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.4%-0.1%+4.0%
Q4 2025-14.8%-9.1%-21.0%
Q3 2025+6.0%+0.4%+0.1%
Q1 2025-6.6%-1.8%-2.7%
Q4 2024+7.4%+7.7%+11.0%
Q3 2024-12.0%-12.7%-6.2%
Q2 2024-0.1%+2.4%+5.7%
Q1 2024-7.0%-8.1%-9.9%
Q4 2023+5.1%+2.6%+7.3%
Q3 2023+9.3%+10.9%+14.4%
Q2 2023-8.1%-8.0%-10.8%
Q1 2023-3.7%-2.2%-4.1%
Q4 2022+3.3%+1.7%+1.9%
Q3 2022+3.2%+4.1%+12.6%
Q2 2022-6.8%-9.2%-8.3%
Q1 2022-1.4%-1.0%+0.8%
Q4 2021+5.1%+5.8%+3.8%
Q3 2021+9.2%+9.0%+9.4%
Q2 2021-4.4%-0.4%-2.4%
Q1 2021+1.5%+2.3%+6.1%
Q4 2020-0.8%-6.7%-3.9%
Q3 2020+1.2%+3.5%+0.2%
Q2 2020+9.0%+10.3%+12.2%
Q1 2020-3.9%-6.5%+5.6%
Q4 2019+3.2%-1.2%-23.1%
Q3 2019-1.7%+0.6%+5.9%
Q2 2019+3.7%+8.1%+13.9%
Q1 2019-0.6%+0.7%+0.3%
Q4 2018+1.3%+2.8%+1.9%
Q3 2018+6.2%+6.6%+7.6%
Q2 2018+0.4%-2.5%+0.1%
Q1 2018+3.0%+3.3%+13.4%
Q4 2017+2.4%+2.1%+12.9%
Q3 2017+9.1%+5.0%+12.7%
Q2 2017-1.1%-2.3%-6.3%
Q1 2017+10.0%+9.4%+9.0%
Q4 2016+1.9%+2.0%+9.1%
Q3 2016-0.3%+1.8%+6.3%
Q2 2016+5.0%+3.0%-7.9%
Q1 2016-6.7%
Q4 2015-5.6%
Q3 2015+13.0%
Q2 2015+5.1%
Q1 2015-4.7%
Q4 2014+7.5%
Q3 2014-1.2%
Q2 2014+4.3%
Q1 2014-3.3%
Q4 2013+10.5%
Q3 2013-5.2%
Q2 2013-7.3%
Q1 2013+3.4%
Q4 2012+4.9%
Q3 2012-2.0%
Q2 2012+5.1%
Q1 2012+2.9%
Q4 2011+0.0%
Q3 2011+1.5%
Q2 2011-5.8%
Q1 2010-2.6%
Q1 2011+1.8%
Q4 2008-1.6%
Q4 2010-1.6%
Q3 2009+1.4%
Q3 2010+1.4%
Q2 2010-0.9%
Q2 2009-0.9%
Q4 2009-0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro